Steve Chamow

Biochemistry PhD and Drug Developer
As a biochemistry PhD with more than 30 years of experience in the field of drug discovery, Steve knows what it takes to develop pharmaceuticals and take them to market.


This speaker doesn't have any events scheduled at the moment. Sign up for our mailing list to stay in the loop about future events.



Dr. Steven Chamow has over 30 years of experience in biopharmaceutical product development. Since 2008, he has served as president of Chamow & Associates, Inc., a consulting group working with biotechnology companies to design and implement strategies to develop new therapeutic products.

In his career, he has contributed to the development of three marketed biologics (Avastin, Natrecor, Vectibix). Prior to his current position, he was Senior Vice President, CMC, at Intradigm Corporation, a private biopharmaceutical company focused on developing RNAi therapeutics (acquired by Silence Therapeutics). Dr. Chamow was Vice President, Process Sciences, at Genitope Corporation and at Abgenix, Inc., (acquired by Amgen) where he built the company’s process sciences department and helped to lead the design and construction of Abgenix’s award-winning production facility in Fremont, CA (sold by Amgen to Boehringer-Ingelheim to become its first North American production facility). Before Abgenix, he served as Director of Biopharmaceutical Development at Scios, Inc. (acquired by J&J), and as a scientist and senior scientist in process development at Genentech, Inc. (acquired by Roche).

Dr. Chamow was educated at the University of California (UC Santa Cruz, B.A. in biology; UC Davis, Ph.D. in biochemistry), and completed postdoctoral training at the National Institutes of Health in Bethesda, MD. He is author or co-author of more than 50 scientific publications and patents and co-editor of two books.


"Steve was very clear and personable. I appreciated his insights and expertise and the plain spoken approach he took to a very complex topic!"

Speakeasy participant

"Excellent and informative."

Speakeasy participant

"Steve's talk was informative and understandable. I appreciated being able to go over the hour mark in order to have many more questions answered."

Speakeasy participant